Sarcopenia and Myosteatosis as Prognostic Markers in Patients with Advanced Cholangiocarcinoma Undergoing Palliative Treatment.
Markus Sebastian JördensLinda WittigLisa HeinrichsVerena KeitelMaximilian Franz Schulze-HagenGerald AntochWolfram T KnoefelGeorg FluegenTom LueddeChristina LobergChristoph RoderburgSven Heiko LoosenPublished in: Journal of clinical medicine (2021)
Routine abdominal CT scans represent a unique opportunity to evaluate sarcopenia as well as myosteatosis in advanced CCA patients. We identified the L3SMI/L3PMI as well as the MMA as negative prognostic factors in CCA patients undergoing palliative therapy, arguing that the "opportunistic" evaluation of these parameters might yield important clinical information in daily routine.
Keyphrases
- magnetic resonance imaging
- prognostic factors
- computed tomography
- patients undergoing
- end stage renal disease
- palliative care
- skeletal muscle
- chronic kidney disease
- clinical practice
- newly diagnosed
- ejection fraction
- positron emission tomography
- peritoneal dialysis
- advanced cancer
- physical activity
- community dwelling